Ikarian Capital, LLC Sage Therapeutics, Inc. Put Options Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
Put Options
2 transactions
Others Institutions Holding SAGE
# of Institutions
218Shares Held
46.4MCall Options Held
847KPut Options Held
188K-
Vanguard Group Inc Valley Forge, PA5.76MShares$33 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.59MShares$32 Million0.64% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$29.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$25.6 Million0.54% of portfolio
-
State Street Corp Boston, MA2.93MShares$16.8 Million0.0% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $340M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...